A client with oliguria has an order for 1000 mL of 0.9% NS over 3 hours. The tubing drop factor is 10 gtt/mL. How many gtt/min should be given? (Round to the nearest whole number. use a leading zero if it applies. Do not use a trailing zero.)

A client who has been anticoagulated with warfarin has been admitted for gastrointestinal bleeding. The history and physical examination indicates that the client may have taken too much warfarin. The nurse anticipates that the client will receive which antidote?

A nurse is assessing a client IS min after administering morphine sulfate 2 mg via IV push. The nurse should identify which of the following findings as an adverse effect of the medication?

A client who has been taking cimetidine for hyperacidity calls the clinic to say that the medication has not been effective. The nurse reviews his history and notes that which factor may be influencing the effectiveness of this drug?

The nurse is reviewing the indications for atropine sulfate. Atropine is appropriate for which of these clients? (Select all that apply.)

A client wants to take the herb gingko to help his memory. The nurse reviews his current medication list and would be concerned about potential interactions if he is taking a medication from which class of drugs?

The nurse is evaluating the laboratory results of a client who has received chemotherapy. The loss of which blood cell leads to lack of energy, fatigue, intolerance of activity and hypoxemia?

During therapy with the hematopoietic drug epoetin alfa, the nurse instructs the client about adverse effects that may occur, such as:

A nurse is caring for a male client who has peripheral vascular disease (PVC)), is taking dietary supplements, and has a new prescription for warfarin. The nurse should instruct the client to stop which of the following supplements prior to starting the warfarin? (Select all that apply.)

During interleukin drug therapy, a client is showing signs of severe fluid retention, with increasing dyspnea and severe peripheral edema. The next dose of the interleukin is due now.

Which action will the nurse take next?

When evaluating a client's use of a metered-dose inhaler (MDI), the nurse notes that the client is unable to coordinate the activation of the inhaler with her breathing. What intervention is most appropriate at this time?